Background/Aims: The coexistence of triple A syndrome (AAAS) and congenital hypogonadotropic hypogonadism (CHH) has so far not been reported in the literature. This study aimed to characterize at the clinical and genetic level one patient presenting an association of AAAS and CHH in order to identify causal mutations. Methods: Clinical and endocrinal investigations were performed and followed by mutational screening of candidate genes. Results: At the age of 18, the patient presented sexual infantilism, a micropenis and gynecomastia. No mutation was revealed in GnRHR, TACR3/TAC3, PROK2/PROKR2 and PROP1 genes, except a homozygous intronic variation (c.244 + 128C>T; dbSNP: rs350129) in the KISS1R gene, which is likely nondeleterious. A homozygous splice-donor site mutation (IVS14 + 1G>A) was found in the AAAS gene. This mutation, responsible for AAAS, is a founder mutation in North Africa. Conclusion: This is the first report on a Tunisian patient with the coexistence of AAAS and CHH. The diagnosis of CHH should be taken in consideration in patients with Allgrove syndrome and who carry the IVS14 + 1G>A mutation as this might challenge appropriate genetic counseling.

Keywords:
Triple A syndrome, Congenital hypogonadotropic hypogonadism, Founder mutation, Comorbidity, ALADIN
1.
Kilicli F, Acibucu F, Senel S, Dokmetas HS: Allgrove syndrome. Singapore Med J 2012;53:e92-e94.
2.
Capataz Ledesma M, Mendez Perez P, Rodriguez Lopez R, Galan Gomez E: Allgrove syndrome (triple A). Finding of a mutation not described in the AAAS gene (in Spanish). An Pediatr (Barc) 2013;78:109-112.
3.
Handschug K, Sperling S, Yoon SJ, Hennig S, Clark AJ, Huebner A: Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Mol Genet 2001;10:283-290.
4.
Cooper DN, Ball EV, Krawczak M: The human gene mutation database. Nucleic Acids Res 1998;26:285-287.
5.
Sarathi V, Shah NS: Triple-A syndrome. Adv Exp Med Biol 2010;685:1-8.
6.
Genin E, Tullio-Pelet A, Begeot F, Lyonnet S, Abel L: Estimating the age of rare disease mutations: the example of Triple-A syndrome. J Med Genet 2004;41:445-449.
7.
Tullio-Pelet A, Salomon R, Hadj-Rabia S, Mugnier C, de Laet MH, Chaouachi B, Bakiri F, Brottier P, Cattolico L, Penet C, et al: Mutant WD-repeat protein in triple-A syndrome. Nat Genet 2000;26:332-335.
8.
Hadj-Rabia S, Salomon R, Pelet A, Penet C, Rotschild A, de Laet MH, Chaouachi B, Hannachi R, Bakiri F, Brauner R, et al: Linkage disequilibrium in inbred North African families allows fine genetic and physical mapping of triple A syndrome. Eur J Hum Genet 2000;8:613-620.
9.
Young J: Approach to the male patient with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2012;97:707-718.
10.
Brioude F, Bouligand J, Trabado S, Francou B, Salenave S, Kamenicky P, Brailly-Tabard S, Chanson P, Guiochon-Mantel A, Young J: Non-syndromic congenital hypogonadotropic hypogonadism: clinical presentation and genotype-phenotype relationships. Eur J Endocrinol 2010;162:835-851.
11.
Pitteloud N, Zhang C, Pignatelli D, Li JD, Raivio T, Cole LW, Plummer L, Jacobson-Dickman EE, Mellon PL, Zhou QY, Crowley WF Jr: Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 2007;104:17447-17452.
12.
Reynaud R, Barlier A, Vallette-Kasic S, Saveanu A, Guillet MP, Simonin G, Enjalbert A, Valensi P, Brue T: An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain. J Clin Endocrinol Metab 2005;90:4880-4887.
13.
Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
14.
Ben Halim N, Ben Alaya Bouafif N, Romdhane L, Kefi Ben Atig R, Chouchane I, Bouyacoub Y, Arfa I, Cherif W, Nouira S, Talmoudi F, et al: Consanguinity, endogamy, and genetic disorders in Tunisia. J Community Genet 2013;4:273-284.
15.
Bchetnia M, Merdassi A, Charfeddine C, Mgaieth F, Kassar S, Ouechtati F, Chouchene I, Boussen H, Mokni M, Osman AD, et al: Coexistence of mal de Meleda and congenital cataract in a consanguineous Tunisian family: two case reports. J Med Case Rep 2010;4:108.
16.
Bchetnia M, Charfeddine C, Kassar S, Zribi H, Guettiti HT, Ellouze F, Cheour M, Boubaker S, Osman AD, Abdelhak S, Mokni M: Clinical and mutational heterogeneity of Darier disease in Tunisian families. Arch Dermatol 2009;145:654-656.
17.
Romdhane L, Kefi R, Azaiez H, Ben Halim N, Dellagi K, Abdelhak S: Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East. Orphanet J Rare Dis 2012;7:52.
18.
Ben Said M, Dhouib H, BenZina Z, Ghorbel A, Moreno F, Masmoudi S, Ayadi H, Hmani-Aifa M: Segregation of a new mutation in SLC26A4 and p.E47X mutation in GJB2 within a consanguineous Tunisian family affected with Pendred syndrome. Int J Pediatr Otorhinolaryngol 2012;76:832-836.
19.
Loueslati BY, Cherni L, Khodjet-Elkhil H, Ennafaa H, Pereira L, Amorim A, Ben Ayed F, Ben Ammar Elgaaied A: Islands inside an island: reproductive isolates on Jerba island. Am J Hum Biol 2006;18:149-153.
20.
Nebel A, Landau-Tasseron E, Filon D, Oppenheim A, Faerman M: Genetic evidence for the expansion of Arabian tribes into the Southern Levant and North Africa. Am J Hum Genet 2002;70:1594-1596.
21.
Kinjo S, Takemoto M, Miyako K, Kohno H, Tanaka T, Katsumata N: Two cases of Allgrove syndrome with mutations in the AAAS gene. Endocr J 2004;51:473-477.
22.
Houlden H, Smith S, De Carvalho M, Blake J, Mathias C, Wood NW, Reilly MM: Clinical and genetic characterization of families with triple A (Allgrove) syndrome. Brain 2002;125:2681-2690.
23.
Topaloglu AK, Kotan LD: Molecular causes of hypogonadotropic hypogonadism. Curr Opin Obstet Gynecol 2010;22:264-270.
24.
Lewkowitz-Shpuntoff HM, Hughes VA, Plummer L, Au MG, Doty RL, Seminara SB, Chan YM, Pitteloud N, Crowley WF Jr, Balasubramanian R: Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications. J Clin Endocrinol Metab 2012;97:E136-E144.
25.
Beate K, Joseph N, Nicolas de R, Wolfram K: Genetics of isolated hypogonadotropic hypogonadism: role of GnRH receptor and other genes. Int J Endocrinol 2012;2012:147893.
26.
Sykiotis GP, Plummer L, Hughes VA, Au M, Durrani S, Nayak-Young S, Dwyer AA, Quinton R, Hall JE, Gusella JF, et al: Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc Natl Acad Sci USA 2010;107:15140-15144.
27.
Houang M, Gourmelen M, Moatti L, Le BY, Garabedian EN, Denoyelle F: Hypogonadotrophic hypogonadism associated with prelingual deafness due to a connexin 26 gene mutation. J Pediatr Endocrinol Metab 2002;15:219-223.
28.
Riahi Z, Hammami H, Ouragini H, Messai H, Zainine R, Bouyacoub Y, Romdhane L, Essaid D, Kefi R, Rhimi M, et al: Update of the spectrum of GJB2 gene mutations in Tunisian families with autosomal recessive nonsyndromic hearing loss. Gene 2013;525:1-4.
29.
Romdhane L, Abdelhak S: Genetic diseases in the Tunisian population. Am J Med Genet A 2011;155A:238-267.
30.
Marin S, Casano-Sancho P, Villarreal-Pena N, Sebastiani G, Pinillos S, Perez-Duenas B, Hwa V, Rosenfeld RG, Ibanez L: Triple A syndrome in a patient with genetic growth hormone insensitivity: phenotypic effects of two genetic disorders. Horm Res Paediatr 2012;77:63-68.
31.
Ismail AF, Mohamed S, Ezz-Elregal M, Talat I, Muthurajan S, Fouda A: Associations with hypoglycemia are useful: a case report of Allgrove syndrome. Turk J Gastroenterol 2012;23:608-609.
32.
Bizzarri C, Benevento D, Terzi C, Huebner A, Cappa M: Triple A (Allgrove) syndrome: an unusual association with syringomyelia. Ital J Pediatr 2013;39:39.
33.
Moschos MM, Margetis I, Koehler K, Gatzioufas Z, Huebner A: New ophthalmic features in a family with triple A syndrome. Int Ophthalmol 2011;31:239-243.
34.
Dumic M, Barisic N, Rojnic-Putarek N, Kusec V, Stanimirovic A, Koehler K, Huebner A: Two siblings with triple A syndrome and novel mutation presenting as hereditary polyneuropathy. Eur J Pediatr 2011;170:393-396.
35.
Mokni N, Younes S, Chebel S, Marzouk K, Huebner A, Ayadi A, Sfar MT: Sclérose latérale amyotrophique et syndrome d'Allgrove chez deux familles. JCC Open 2013;1:49-53.
36.
Dodé C, Teixeira L, Levilliers J, Fouveaut C, et al: Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet 2006;2:e175.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.